- Home
- CFFI vs ENLV Comparison
CFFI vs ENLV Comparison
Compare CFFI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFFI | ENLV |
|---|---|---|
| Founded | 1927 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.1M | 196.2M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CFFI | ENLV |
|---|---|---|
| Price | $74.49 | $0.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 2.7K | ★ 313.8K |
| Earning Date | 04-23-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ 37.94 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $140,841,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $36.77 | ★ N/A |
| Revenue Growth | ★ 10.63 | N/A |
| 52 Week Low | $58.00 | $0.66 |
| 52 Week High | $80.99 | $2.10 |
Technical Indicators
Market Signals| Indicator | CFFI | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 54.63 |
| Support Level | $73.36 | $0.77 |
| Resistance Level | $78.72 | $1.23 |
| Average True Range (ATR) | 1.65 | 0.05 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 68.06 | 88.89 |
Price Performance
Historical ComparisonAbout CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.